Results 171 to 180 of about 774,099 (307)

PowerPoint Slides for: Oxidative Balance Score and the Risk of End-Stage Renal Disease and Cardiovascular Disease

, 2017
Titilayo O. Ilori, X. Wang, Meirong Huang, Orlando M. Gutiérrez, Narayan K.M.V., Morris Goodman, William Mcclellan, Laura Plantinga, Akinlolu Ojo   +8 more
openalex   +1 more source

DOT1L Drives Endothelial‐to‐Mesenchymal Transition and Fibrotic Vascular Remodeling via H3K79 Methylation

Advanced Science, EarlyView.
DOT1L as a central epigenetic regulator of EndoMT and pulmonary fibrosis. Acting as an early epigenetic switch, it translates TGFβ–SMAD signaling into H3K79me2‐mediated chromatin remodeling, selectively activates fibrosis‐related genes, and primes ECs for rapid mesenchymal transition.
Yaofeng Wang, Xing Peng, Jingjing Chen, Yun Zhang, Tinghong Zhang, Jingyuan Zhang, Jiaying Fan, Hui Zheng, Qiaoyuan Liu, Zhimin Song, Zhan‐Peng Huang, Shu Meng   +11 more
wiley   +1 more source

Prevalence of caregiver burden among caregivers of end-stage renal disease patients and the associating factors: A cross-sectional study in a chronic kidney disease clinic in Muang District, Lamphun Province, Thailand

, 2021
K Promsakun, Nalinee Yingchankul
openalex   +2 more sources

Persistence of coronavirus disease 2019 (COVID-19) in patients with end-stage renal disease; an unrecognized phenomenon? [PDF]

, 2020
Macaulay Onuigbo
openalex   +1 more source

High‐Fidelity Synthetic Data Replicates Clinical Prediction Performance in a Million‐Patient Diabetes Cohort

Advanced Science, EarlyView.
This study generates high‐fidelity synthetic longitudinal records for a million‐patient diabetes cohort, successfully replicating clinical predictive performance. However, deeper analysis reveals algorithmic biases and trajectory inconsistencies that escape standard quality metrics. These findings challenge current validation norms, demonstrating why a
Francisco Ortuño, Víctor M. de la Oliva Roque, Javier‐Ignacio Ramirez‐Lopez, David P. Kreil, Joaquín Dopazo, Carlos Loucera   +5 more
wiley   +1 more source

The Methylation Profile of IFN-γ, SOCS1 and SOCS3 Promoter Regions in End-Stage Renal Disease

, 2013
Maivel Ghattas Fatma El-shaarawy
openalex   +1 more source

Entecavir treatment for chronic hepatitis B infection in end‐stage renal disease and kidney transplantation [PDF]

, 2010
Ezequiel Ridruejo, Raúl Adrover, Cristina Alonso, Oscar G. Mandό, Marcelo Silva   +4 more
openalex   +1 more source

β‐Adrenergic Signaling Promotes Anti‐Tumor Immunity in TP53‐mutant Oral Squamous Cell Carcinoma

Advanced Science, EarlyView.
β‐adrenergic stimulation enhances anti‐tumor immunity in TP53‐deficient oral squamous cell carcinoma by inducing tumor‐derived secretion of CXCL10, which attracts and activates cytotoxic CD8+ T cells. The findings demonstrate that β‐adrenergic signaling alters tumor–immune interactions via CXCL10‐mediated paracrine activation, revealing a neuro‐immune ...
Frederico O. Gleber‐Netto, Deborah Silverman, Tongxin Xie, Shamima Akhter, Nicole R. Vaughn, Adewale Adebayo, Kala Chand Debnath, Shorook Naara, Shajedul Islam, Erik Knutsen, Emily Lorin Ashkin, Simone Anfossi, Sara Leahey, Patrick Hwu, Sebastien Talbot, Erica K Sloan, Robert Saddawi‐Konefka, Roberto Rangel, Jeffrey N. Myers, George A. Calin, Moran Amit   +20 more
wiley   +1 more source

Clinical use of rocuronium in patients with end-stage renal disease

, 2009
Soo Kyung Lee
openalex   +1 more source

Arterial Calcifications, Arterial Stiffness, and Cardiovascular Risk in End-Stage Renal Disease

HYPERTENSION, 2001
J. Blacher, A. Guérin, B. Pannier, S. Marchais, G. London   +4 more
semanticscholar   +1 more source